CCL5 and colorectal carcinoma: CMS1 CRC is more inclined to high expression of CCL5 compared to other consensus molecular subtypes (76), and the TME of CMS1 CRC is heavily infiltrated and activates infiltrating immune cells (CD8+ T, CD40 ligand, helper T cells, NK).